Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism.

Abstract

Autism spectrum disorder is a neurodevelopmental disorder marked by repetitive behaviour, challenges in verbal and non-verbal communication, poor socio-emotional health, and cognitive impairment. An increased level of signal transducer and activator of transcription 3 (STAT3) and a decreased level of peroxisome proliferator-activated receptor (PPAR) gamma have been linked to autism pathogenesis. Guggulsterone (GST) has a neuroprotective effect on autistic conditions by modulating these signalling pathways. Consequently, the primary objective of this study was to examine potential neuroprotective properties of GST by modulating JAK/STAT and PPAR-gamma levels in intracerebroventricular propionic acid (ICV PPA) induced experimental model of autism in adult rats. In this study, the first 11 days of ICV-PPA injections in rats resulted in autism-like behavioural, neurochemical, morphological, and histopathological changes. The above modifications were also observed in various biological samples, including brain homogenate, CSF, and blood plasma. GST was also observed to improve autism-like behavioural impairments in autistic rats treated with PPA, including locomotion, neuromuscular coordination, depression-like behaviour, spatial memory, cognition, and body weight. Prolonged GST treatment also restored neurochemical deficits in a dose-dependent manner. Chronic PPA administration increased STAT3 and decreased PPAR gamma in autistic rat brain, CSF, and blood plasma samples, which were reversed by GST. GST also restored the gross and histopathological alterations in PPA-treated rat brains. Our results indicate the neuroprotective effects of GST in preventing autism-related behavioural and neurochemical alterations.

• Authors: Rishabh Khera, Sidharth Mehan, Sonalika Bhalla, Sumit Kumar, Abdulrahman Alshammari, Metab Alharbi, Satya Sai Sadhu
• Journal: Molecules (Basel, Switzerland) (Molecules) Vol. 27 Issue 3 (Jan 28 2022) ISSN: 1420-3049 [Electronic] Switzerland
• PMID: 35164154 (Publication Type: Journal Article)

Chemical References

• Neuroprotective Agents
• PPAR gamma
• Pregnenediones
• Propionates
• STAT Transcription Factors
• pregna-4,17-diene-3,16-dione
• Janus Kinases
• propionic acid

Topics

• Animals
• Autism Spectrum Disorder (chemically induced, drug therapy, metabolism)
• Disease Models, Animal
• Female
• Janus Kinases (metabolism)
• Male
• Neuroprotective Agents (therapeutic use)
• PPAR gamma (metabolism)
• Pregnenediones (therapeutic use)
• Propionates
• Rats, Wistar
• STAT Transcription Factors (metabolism)
• Signal Transduction (drug effects)
• Rats